Insider Transactions in Q1 2023 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2023
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
714
-1.2%
|
$14,994
$21.78 P/Share
|
|
Mar 17
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
1,230
-0.38%
|
$25,830
$21.78 P/Share
|
|
Mar 17
2023
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
665
-1.19%
|
$13,965
$21.78 P/Share
|
|
Mar 17
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,230
-1.21%
|
$25,830
$21.78 P/Share
|
|
Mar 10
2023
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
100,000
+3.06%
|
$2,000,000
$20.64 P/Share
|
|
Mar 07
2023
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
550,000
+23.87%
|
$12,100,000
$22.0 P/Share
|
|
Mar 01
2023
|
Mark A Goldsmith |
BUY
Grant, award, or other acquisition
|
Direct |
104,000
+22.62%
|
-
|
|
Mar 01
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+28.31%
|
-
|
|
Mar 01
2023
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+10.88%
|
-
|
|
Mar 01
2023
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
29,000
+32.76%
|
-
|
|
Mar 01
2023
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,600
+32.24%
|
-
|
|
Feb 22
2023
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+15.16%
|
$0
$0.49 P/Share
|